Complete Genomics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Complete Genomics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12334
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Complete Genomics Inc (Complete Genomics), a subsidiary of BGI Genomics Co Ltd, is a human genome sequencing solutions provider. The company offers sequencing technology, process automation technology and data management solutions. It has sequenced whole human genomes using sequencing instruments, chemistry and software. Complete Genomics’ components of sequencing technology include DNA nanoball arrays and combinatorial probe-anchor ligation reads. The company’s human genome sequencing technology consists of proprietary sequencing technology, complete data management solution and DNB Nanoball Arrays. It builds next-generation sequencing systems and applications for the research, clinical, and consumer markets. Complete Genomics is headquartered in San Jose, California, the US.

Complete Genomics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Complete Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Complete Genomics Inc, Medical Devices Deals, 2012 to YTD 2018 8
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Complete Genomics Spin-Off Genos Research 10
Complete Genomics Announces Public Offering Of Shares For US$30 Million 11
Acquisition 12
BGI Shenzhen Completes Acquisition Of Complete Genomics For US$118 Million 12
Complete Genomics Inc – Key Competitors 14
Complete Genomics Inc – Key Employees 15
Complete Genomics Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Complete Genomics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Complete Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Complete Genomics Inc, Medical Devices Deals, 2012 to YTD 2018 8
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Complete Genomics Spin-Off Genos Research 10
Complete Genomics Announces Public Offering Of Shares For US$30 Million 11
BGI Shenzhen Completes Acquisition Of Complete Genomics For US$118 Million 12
Complete Genomics Inc, Key Competitors 14
Complete Genomics Inc, Key Employees 15

List of Figures
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Complete Genomics Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Complete Genomics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Livzon Pharmaceutical Group Inc (000513):製薬・医療:M&Aディール及び事業提携情報
    Summary Livzon Pharmaceutical Group Inc (Livzon), a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and inte …
  • Vector Group Ltd.:企業の戦略・SWOT・財務情報
    Vector Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Vector Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Infectious Disease Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary Infectious Disease Research Institute (IDRI) is a nonprofit healthcare institute that provides various pharmaceutical products and services. The institute provides vaccines, drugs and diagnostics for several infectious diseases and conducts researches. Its products include adjuvants, drugs, …
  • Metlifecare Ltd (MET)-製薬・医療分野:企業M&A・提携分析
    Summary Metlifecare Ltd (Metlifecare) is a healthcare service provider that owns and manages retirement villages to older citizens in New Zealand. The center provides retirement villages provide services such as healthcare services, security, community and companionship, maintenance free living and …
  • Burnet Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Burnet Institute is a non-profit and independent organization that improves health of poor and vulnerable communities through research, education and public health. The institute offers solutions to major health issues through development and discovery of novel vaccines, diagnostic tests and …
  • ERG SpA (ERG):企業の財務・戦略的SWOT分析
    ERG SpA (ERG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Mitsubishi Electric Corp (6503):企業の財務・戦略的SWOT分析
    Mitsubishi Electric Corp (6503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • DPR Construction Inc:企業の戦略的SWOT分析
    DPR Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • The Charles Schwab Corporation:企業のM&A・事業提携・投資動向
    The Charles Schwab Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Charles Schwab Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Avalon Oil & Gas Inc (AOGN):企業の財務・戦略的SWOT分析
    Summary Avalon Oil & Gas Inc (Avalon), is an oil and gas company that develops and operates crude oil and natural gas properties. The company acquires, produces and develops oil and natural gas reserves. It offers reservoir maintenance and technologies to produce portfolio of oil and gas leases in t …
  • MTR Corporation Ltd:戦略・SWOT・企業財務分析
    MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Acuity Brands Inc (AYI)-エネルギー分野:企業M&A・提携分析
    Summary Acuity Brands, Inc. (Acuity Brands) provides lighting and building management solutions and services. The company offers lighting solutions including devices such as luminaires, lighting controls, lighting components, power supplies, prismatic skylights, and integrated lighting systems. It a …
  • NuVasive Inc (NUVA)-医療機器分野:企業M&A・提携分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Nine Dragons Paper (Holdings) Ltd:企業の戦略・SWOT・財務分析
    Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Frutarom Industries Ltd (FRUT):企業の財務・戦略的SWOT分析
    Frutarom Industries Ltd (FRUT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Taiwan High Speed Rail Corporation:企業の戦略・SWOT・財務分析
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • J.K. Cement Ltd. (JKCEMENT):企業の財務・戦略的SWOT分析
    J.K. Cement Ltd. (JKCEMENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • RockBridge Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    RockBridge Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary RockBridge Resources Inc (RockBridge) is an oil and gas exploration and development company. The company acquires, develops and explores oil and gas properties. Its properties include Twinning a …
  • Sprott Resource Holdings Inc. (SRHI):企業の財務・戦略的SWOT分析
    Sprott Resource Holdings Inc. (SRHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Oncolytics Biotech Inc (ONC):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of l …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆